Navigation Links
Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
Date:3/23/2009

ral neck and total hip BMD, serum bone turnover markers, mammographic breast density and safety.(1) The study included postmenopausal women with osteoporosis with a mean age of 63 years and a mean lumbar spine BMD T-score of -2.9.

12-month results included:(1)

  • Arzoxifene significantly increased BMD at all sites to a greater extent than raloxifene, respectively (p<0.05 for all comparisons):
    • Lumbar spine BMD (2.8 percent vs. 1.7 percent)
    • Femoral neck BMD (1.5 percent vs. 0.5 percent)
    • Total hip BMD (1.5 percent vs. 0.8 percent)
    • For lumbar spine and femoral neck, this effect was statistically significant as early as six months.
  • Arzoxifene significantly suppressed bone turnover to a greater extent than raloxifene, respectively (p<0.05 for all comparisons):
    • CTX (biochemical marker of bone resorption); -40.6 percent vs. -29.8 percent
    • PINP (biochemical marker of bone formation) : -41.5 percent vs. -30.8 percent
    • Arzoxifene suppressed bone turnover to a greater extent than raloxifene as early as three months.
  • New or worsening hot flushes were reported less frequently with arzoxifene versus raloxifene (7.0 percent vs. 16.7 percent; p=0.009).
  • There were not any between-group or within-group differences in change of percentage of breast density.
  • The proportion of women reporting one or more adverse events, including vaginal bleeding, did not differ between treatment groups.
  • No cases of endometrial polyps, hyperplasia or cancer were reported.
  • Nasopharyngitis and bronchitis were reported more frequently with arzoxifene versus raloxifene (10.1 percent vs. 2.5 percent, and 5.1 percent vs. 0 percent, respectively; p less than or equal to 0.
    '/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
2. Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
3. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
4. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
5. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
6. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
7. Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... NEW YORK , May 26, 2015  Shapiro+Raj, ... Kim Mizrahi , PhD, to Managing Director. In ... York strategy for CarbonSix, Shapiro+Raj,s pharmaceutical practice ... capability. Shapiro+Raj has been on a strong ... adding a number of new assignments from existing clients ...
(Date:5/26/2015)... 2015  Caris Life Sciences®, a leading biotechnology company ... announced the designation of Virginia Cancer Specialists ... serving thousands of cancer patients each year ... center of excellence site in the Caris Centers of ... "As the largest community-based practice in the northern ...
(Date:5/26/2015)... 26, 2015 For the Last ... of Life Throughout Europe, the Middle East ... Astellas Pharma EMEA is celebrating its 10 year ... the historic merger of Japanese pharmaceutical companies Yamanouchi and ... to turning science into value for patients through its ...
Breaking Medicine Technology:Shapiro+Raj Promotes Kim Mizrahi to Managing Director for New York 2Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 2Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 3Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 4Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4
... Sangart, Inc., a privately,held biopharmaceutical company focused ... today announced that it has,completed enrollment in a ... The completed study of 460 patients is ... conducted at 36 academic medical centers in the,United ...
... After completing its review of safety,and efficacy ... (DSMB) has once again recommended that the two ... FAME(TM) (Fluocinolone,Acetonide in Diabetic Macular Edema) Study can ... is studying the use of Medidur FA for,the ...
Cached Medicine Technology:Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 3
(Date:5/26/2015)... 26, 2015 Abington is pleased ... a physician practice with seven medical professionals, has ... eighth primary-care site in the United States to ... home by the National Committee for Quality Assurance. ... preventative and sick care – including routine gynecology ...
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 Two ... recently joined Dr. Marissa Pei on a ... conversation focusing on addiction. Aired on KCAA AM 1050, ... Deena Duncan, marriage and family therapist, as they discuss ... estimated to affect more than 23.5 million Americans. The ...
(Date:5/26/2015)... May 26, 2015 CIO Review has chosen ... Promising Pharma and Life Sciences Technology Solution Providers. The positioning ... 11 compliant solution which is applicable across the entire security ... necessary for broad adoption. , “SIGNiX has been on ... the Pharma and Life Sciences Technology space, and we are ...
(Date:5/26/2015)... National Prevention Week , National Prevention Week is ... by the Substance Abuse and Mental Health Services Administration ... action about, substance abuse as well as mental health ... to join in promoting prevention strategies, in educating other ... building community partnerships. , The Voice of One, the ...
(Date:5/26/2015)... Scientists at the University of Pennsylvania ... advanced mesothelioma patients benefit from immunotherapy; surgery may be ... on the new research. Click here to read ... thoracic surgery and pulmonology theorized that, because large mesothelioma ... attack, immunotherapy drugs might work better if the tumor ...
Breaking Medicine News(10 mins):Health News:Family Medicine, Geriatrics and Wellness Joins Abington Health Physicians 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2
... Nov. 12 Governor Jennifer M.,Granholm, Attorney General ... Barrett today kicked off the 4th Annual "Support ... raises funds to,support Michigan soldiers, sailors, and Marines ... benefit the Bob Woodruff Family,Fund founded by Michigan ...
... personalized portal for referring ... ... AMCS ),a leader in radiology and medical image and information management,solutions, ... that can help imaging businesses grow by attracting,referrals and securing referring ...
... eDiets.com,Inc. (Nasdaq: DIET ), leveraging the ... both consumers and businesses, today announced that it,has ... will report results for its third quarter ended ... on Wednesday, November 14, 2007 and,will host a ...
... may be tied to weight , , MONDAY, Nov. 12 (HealthDay ... health problems, new research suggests that fat men are twice ... than men of normal weight. , The research doesn,t confirm ... death from prostate cancer, and it,s not clear if losing ...
... researchers have developed a small molecule that can turn the ... death signal. The molecule mimics the activity of Smac, a ... cells. ,The researchers say their findings suggest that Smac-mimetic ... and other cancers. Such therapy may be less toxic to ...
... Health releases nationwide eValue8,findings, SCOTTSDALE, Ariz., ... report of health plan performance released today ... (NBCH), health plans could do a,better job ... enabling,improvements in patient safety, care coordination, consumer ...
Cached Medicine News:Health News:Governor Granholm, Attorney General Cox, & Michigan Chamber Kick Off 4th Annual 'Support MI Troops' Fundraising Drive Proceeds to Benefit the Bob Woodruff Family Fund 2Health News:AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow 2Health News:AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow 3Health News:eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call 2Health News:Obesity Linked to Prostate Cancer Death Rates 2Health News:Obesity Linked to Prostate Cancer Death Rates 3Health News:Smac-ing lung cancer to death 2Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 2Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 3Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 4
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: